Skip to main content

Faculty & STAFF representatives OF the Advisory council

Faculty Representatives

There shall be a minimum of four (4) faculty representatives to the Council (three-year term, renewable. Two shall be selected from the Life Sciences, one shall be selected from Physical Sciences and Engineering, and one shall be selected from the Johnson School or Dyson School.

Jocelyn Rose, PhD, Vice Chair, and Life Sciences Representative

Jocelyn completed his undergraduate degree in Biology at the University of Manchester, UK before working for a couple of years for what was previously ICI Seeds (later named Zeneca Plant Science and then Syngenta) at Jealotts’s Hill Research Station, Berkshire, UK.

He made the jump across the Atlantic to study for his Ph.D. at UC Davis, working on the cell wall biology of fruit ripening under his advisor Alan Bennett. In 1997 he moved to the Complex Carbohydrate Research Center, University of Georgia, to work in the lab of Peter Albersheim and Alan Darvill, where his research was focused on cell wall metabolism in the context of plant-pathogen interactions.

In 2000, he accepted a faculty position in the Department of Plant Biology at Cornell University where he has continued his interests in the many facets of plant cell wall biology and their societal importance.

In 2010 Jocelyn accepted the positions of Director of the Institute of Biotechnology and Director of the Center for Life Science Enterprise, one of NY State's Centers for Advanced Technology. He is also operational manager for the McGovern Family Center for Venture Development in the Life Sciences.

Bruce Ganem, PhD, Johnson School and Physical Sciences Representative

Dr. Bruce Ganem, Ph.D. is a Co-Founder of KensaGroup, LLC and serves as its Chief Scientific Officer. As a scientist-entrepreneur, Dr. Ganem has founded or helped start several biopharmaceutical and technology companies in the past fifteen years, including LeukoSite, ArQule, Natural Pharmaceuticals, Inc., Taktix, Gene Network Sciences, NovaSterilis, Medhesives, North Sea Resins, and Novomer. He is a North American Executive Editor of Tetrahedron Letters, an international chemistry journal, and has served on the editorial boards of the Canadian Journal of Chemistry, Chemtracts, the Encyclopedia of Analytical Chemistry, and VCH Publishers. In addition he was consulting Chemistry Editor for the 1999 Encarta World English Dictionary.

Dr. Ganem serves as Director and Member of the Scientific Advisory Board of KensaGroup LLC. He served as a Member of the Scientific Advisory Board at Novomer, Inc., and Amicus Therapeutics, Inc. He authored over 240 scientific papers, and holds five patents. Dr. Ganem serves as an Adjunct Professor of Entrpreneurship at Cornell's S.C. Johnson Graduate School of Management. He is a J. Thomas Clark Professor of Entrepreneurship and Personal Enterprise and Franz and Elisabeth Roessler Professor of Chemistry College of Arts and Sciences at Cornell University. Dr. Ganem joined the Cornell faculty in 1974, serving as Department chairman from 1993 to 1997 and again since 2001.

A synthetic organic chemist by training, he has broad scientific research interests ranging from organic and analytical chemistry to biochemistry and molecular medicine, including medicinal chemistry, structure-based drug design, protein engineering, and biotechnology. Dr. Ganem is the recipient of numerous awards and honors, including the 1999 Chemical Manufacturers Association National Catalyst Award and the 2007 American Chemical Society Award for Creative Invention. Dr. Ganem received his B.A degree in Chemistry from Harvard College and his Ph.D in Organic chemistry from Columbia University. He completed Postdoctoral work at Stanford.

Martin Wiedmann, PhD, Life Sciences Representative

Martin Wiedmann is a Professor in the Department of Food Science. He received a Veterinary Degree (D.V.M. equivalent) and Dr. med. vet. (Ph.D. equivalent) in Veterinary Medicine both from the University of Munich, Germany and a Ph.D. in Food Science from Cornell University.

He joined the Cornell faculty in 1999 and is a member of the Graduate Fields of Food Science, Microbiology, and Comparative Biomedical Sciences. He serves as co-coordinator of the Cornell Food and Water Safety Program, and he participates in the Infection and Pathobiology Program, the Cornell Center for Comparative and Population Genomics (3CPG), and in the Cornell Genomics Initiative. He teaches Food Science 607 "Advanced Food Microbiology", Food Science 351 "Milk Quality", Food Science 406 "Dairy and Food Fermentations" and VTMED 741 Microbial Safety of Animal-Based Foods . In addition, he serves as the director of the Cornell Institute of Food Science Summer Scholar Program. Martin is also the director of the Cornell Laboratory of Molecular Typing. Martin has served on the Editorial Board of the American Journal of Veterinary research (1999-2001) and currently serves on the editorial boards of the Journal of Food Protection and Applied and Environmental Microbiology.

Zachary Shulman, JD, Johnson School Representative

Zach Shulman teaches courses on venture capital and law for high-growth businesses. Shulman is also currently a managing partner at Cayuga Venture Fund, a venture capital firm located in Ithaca, New York. 

Before coming to Johnson in 2002, Shulman served as general counsel and chief investor relations officer of Spike Broadband Systems, where he was responsible for general oversight of Spike's legal function, including negotiating and closing strategic and business relationships; strategizing, negotiating and closing fund-raising efforts; investor relations; and various human resource matters. While at Spike, Shulman negotiated and closed more $80 million in venture capital financing.

Shulman participates in the university-wide Entrepreneurship@Cornell (E@C) initiative and serves on numerous advisory boards for groups affiliated with Cornell and the local community. He earned a bachelor of science from the Cornell University School of Industrial and Labor Relations and graduated from Cornell University Law School, magna cum laude.

David Putnam, PhD, Engineering College Representative

David Putnam joined the College of Engineering at Cornell University in 2002. Prior to joining the engineering faculty, he was an NIH postdoctoral fellow in the Department of Chemical Engineering at MIT in the laboratory of Professor Robert Langer. From 2000 until 2002, he held a joint appointment MIT and as a Scientific co-Founder of a start-up company, TransForm Pharmaceuticals, Inc., which was acquired by Johnson & Johnson in March, 2005. In 2008-2009 he was an Entrepreneur-in-Residence at PureTech Ventrures in Boston, MA where he focused on emerging technologies in the field of drug delivery. He is currently a member of seven Editorial Advisory Boards including Pharmaceutical Research, Journal of Controlled Release, Analytical Biochemistry and Experimental Biology and Medicine. His funding sources include NIH, NSF, the Coulter Foundation and the Department of Defense. He is a Fellow of AIMBE (reserved for the top 2% of Biomedical Engineers in the United States) and the Coulter Foundation. He received his B.S. in Pharmacy from Union University and his Ph.D. in Pharmaceutical Chemistry from the University of Utah.

 

 

Staff Representatives

Xiang Li, TEC Director, Technology Commercialization & Liaison - Ithaca Office